Trokendi XR 25 MG capsule 30S
Ended Awarded Last action
- Contract number
- SPE2DR26FVYL8
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $6,064
Award facts
- Contract value 100% obligated
- $6,063.98 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $6,063.98 to AmerisourceBergen Drug Corp for the supply of Trokendi XR 25 mg capsules (30-count packaging) on January 22, 2026, with completion scheduled for January 23, 2026. This firm fixed-price delivery order was competitively awarded without set-aside designation and will be performed at the contractor's Conshohocken, Pennsylvania facility. The award represents a task order issued under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, a $999.999 billion vehicle valued through December 2026 that serves as the primary mechanism for delivering comprehensive pharmaceutical and medical supplies to support military healthcare programs globally.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, regularly fulfills federal medical procurement requirements through the DLA supply chain. Trokendi XR is a topiramate-based neurological treatment used for epilepsy and migraine prevention, reflecting the contractor's extensive portfolio of pharmaceutical products spanning multiple therapeutic domains including specialty medications, brand-name and generic drugs, and medical supplies. The company's consistent success in competitively awarded contracts with DLA demonstrates its established capability to meet federal healthcare procurement standards and support military treatment facilities and veteran healthcare programs.
Quick answers
Who was awarded contract SPE2DR26FVYL8?
SPE2DR26FVYL8 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 22, 2026.
How much is contract SPE2DR26FVYL8 worth?
The government has obligated $6,064 on SPE2DR26FVYL8.
Is contract SPE2DR26FVYL8 an order under another contract?
Yes. SPE2DR26FVYL8 is a delivery order under SPE2DR25D3002, an indefinite delivery contract.
Was contract SPE2DR26FVYL8 competed?
The extent of competition for SPE2DR26FVYL8 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award